Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 72
Beam-on PET tracks proton dose in real-time
By
Tami Freeman, PhD
Exploiting the superior dose deposition of particle therapy for clinical benefit necessitates an accurate technique for verifying dose delivery. Because the treatment beam stops inside the patient, such monitoring requires detection of secondary radiation created when the incident beam interacts with the tissue, Dutch researchers found.
November 25, 2015
BIR approves Piramal PET reader training course
By
AuntMinnieEurope.com staff writers
The British Institute of Radiology (BIR) has endorsed radiopharmaceutical firm Piramal Imaging's PET reader training course to help detect beta-amyloid plaques in patients with cognitive impairment.
November 24, 2015
ESR unveils plan for new hybrid imaging society
By
Frances Rylands-Monk
The European Society of Radiology (ESR) is set to welcome the European Society for Hybrid Medical Imaging under its umbrella, in line with efforts to increase training in nuclear medicine. Dr. Katrine Riklund will preside over the new society, and the official launch will take place at ECR 2016.
November 22, 2015
Rubidium PET/CT reveals vascular problems in diabetes patients
By
Eric Barnes
Danish researchers have found high rates of microvascular disease using PET/CT with a rubidium radiopharmaceutical in diabetes patients without symptoms of heart disease. The disease was exacerbated in the setting of albuminuria, a common condition in these patients, according to a new study in
Diabetologia
.
November 15, 2015
Mirada wins contract for 30 U.K. centers
By
AuntMinnieEurope.com staff writers
Medical imaging software developer Mirada Medical announced its XD3 Advanced image review and analysis software is being used by Alliance Medical in partnership with 30 National Health Service (NHS) hospital PET/CT departments nationwide.
November 9, 2015
Europe's radiopharma market to reach 1.5B euros by 2020
By
AuntMinnieEurope.com staff writers
The European nuclear medicine and radiopharmaceuticals market will be worth 1.5 billion euros by 2020 compared with 1.0 billion euros in 2015, according to a new report by Markets & Markets.
November 8, 2015
Three-pronged glioma therapy shows promise
By
Jude Dineley
A combination of x-rays, chemotherapy, and a radiosensitizing drug more than doubled tumor cell death in vitro compared with a radiation-only control, according to Australian research. The combination selectively targets tumor cells and can reduce side effects in patients.
November 4, 2015
RCR releases guidance on hybrid imaging
By
AuntMinnieEurope.com staff writers
The U.K. Royal College of Radiologists (RCR) has published a new position statement on the reporting of hybrid imaging studies such as PET/CT, SPECT/CT, and PET/MR.
October 27, 2015
Lightpoint gets CE Mark for molecular imaging device
By
AuntMinnieEurope.com staff writers
Luminescence imaging technology developer Lightpoint Medical has obtained CE Mark approval for its LightPath imaging system, an intraoperative molecular imaging device.
October 19, 2015
FDG-PET predicts survival in Parkinsonian syndrome
By
Wayne Forrest
FDG-PET strongly predicts overall survival in patients suspected of having early-stage atypical Parkinsonian syndrome, according to a study in the October
Journal of Nuclear Medicine
. The modality's findings closely matched clinical diagnosis at one-year follow-up.
October 18, 2015
Gamma Medica receives CE Mark for breast system
By
AuntMinnieEurope.com staff writers
Gamma Medica has received a CE Mark for the sale and distribution of its LumaGem molecular breast imaging (MBI) system within the European economic area.
October 12, 2015
MR targeting directs cancer-killing cells
By
Pearl Toh
Conventional cancer treatments using chemotherapy drugs can suffer from nonspecificity. New research shows MRI can direct cancer-killing cells to target sites. Not only does this technology target cancer kills, it enables anticancer agents to reach tumor sites that are normally inaccessible.
October 1, 2015
Previous Page
Page 72 of 122
Next Page